Aquestive Therapeutics ROA 2018-2018 | AQST

Current and historical return on assets (ROA) values for Aquestive Therapeutics (AQST) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Aquestive Therapeutics ROA for the three months ending September 30, 2018 was 0.00%.
Aquestive Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.04B $0.09B -99.42%
2018-06-30 $-0.04B $0.04B -168.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.207B $0.000B
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.934B 11.08
Zoetis (ZTS) United States $42.722B 29.25
Grifols (GRFS) Spain $12.967B 15.82
Tilray (TLRY) United States $9.050B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.424B 12.09
Neurocrine Biosciences (NBIX) United States $7.781B 1716.20
Ionis Pharmaceuticals (IONS) United States $7.337B 0.00
Nektar Therapeutics (NKTR) United States $6.345B 9.10
Catalent (CTLT) United States $5.190B 21.77
Impax Laboratories (AMRX) United States $5.043B 26.81
Sage Therapeutics (SAGE) United States $5.043B 0.00
United Therapeutics (UTHR) United States $4.729B 7.73
Loxo Oncology (LOXO) United States $4.145B 0.00
TESARO (TSRO) United States $4.078B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.527B 13.06
FibroGen (FGEN) United States $3.318B 0.00
USANA Health Sciences (USNA) United States $2.882B 24.53
Endo (ENDP) Ireland $2.546B 3.90
Xencor (XNCR) United States $2.110B 0.00
Heron Therapeutics (HRTX) United States $2.101B 0.00
Endocyte (ECYT) United States $1.958B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.904B 257.28
Ironwood Pharmaceuticals (IRWD) United States $1.895B 0.00
Aerie Pharmaceuticals (AERI) United States $1.820B 0.00
Zogenix (ZGNX) United States $1.808B 0.00
PTC Therapeutics (PTCT) United States $1.742B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.738B 0.00
Corcept Therapeutics (CORT) United States $1.499B 22.00
Theravance Biopharma (TBPH) Cayman Islands $1.496B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.457B 20.49
Esperion Therapeutics (ESPR) United States $1.419B 0.00
Portola Pharmaceuticals (PTLA) United States $1.388B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.360B 0.00
Tricida (TCDA) United States $1.338B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.202B 0.00
TherapeuticsMD (TXMD) United States $1.037B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.993B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.807B 0.00
ImmunoGen (IMGN) United States $0.802B 0.00
Radius Health (RDUS) United States $0.726B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Karyopharm Therapeutics (KPTI) United States $0.613B 0.00
Forty Seven (FTSV) United States $0.575B 0.00
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.516B 0.00
ChemoCentryx (CCXI) United States $0.507B 40.16
Akebia Therapeutics (AKBA) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.493B 0.00
GlycoMimetics (GLYC) United States $0.463B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.458B 0.00
Dermira (DERM) United States $0.456B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.447B 26.36
Dova Pharmaceuticals (DOVA) United States $0.435B 0.00
Xeris Pharmaceuticals (XERS) United States $0.424B 0.00
Tyme Technologies (TYME) United States $0.407B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
KalVista Pharmaceuticals (KALV) United States $0.405B 0.00
ArQule (ARQL) United States $0.387B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.387B 0.00
Translate Bio (TBIO) United States $0.384B 0.00
CASI Pharmaceuticals (CASI) United States $0.372B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.362B 0.00
Aclaris Therapeutics (ACRS) United States $0.335B 0.00
OptiNose (OPTN) United States $0.330B 0.00
Tapimmune (MRKR) United States $0.327B 0.00
Minerva Neurosciences (NERV) United States $0.309B 0.00
Aratana Therapeutics (PETX) United States $0.307B 0.00
Majesco Entertainment (PTE) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Depomed (ASRT) United States $0.272B 10.12
IMV INC (IMV) Canada $0.265B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.262B 0.00
Mast Therapeutics (SVRA) United States $0.260B 0.00
Aldeyra Therapeutics (ALDX) United States $0.245B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.241B 0.00
Ocular Therapeutix (OCUL) United States $0.230B 0.00
Affimed (AFMD) Germany $0.223B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.212B 0.00
Lannett Co Inc (LCI) United States $0.210B 1.83
Galectin Therapeutics (GALT) United States $0.207B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.207B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.191B 0.00
Opexa Therapeutics (ACER) United States $0.191B 0.00
Zafgen (ZFGN) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
MEI Pharma (MEIP) United States $0.179B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.172B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 0.00
Recro Pharma (REPH) United States $0.169B 0.00
ContraFect (CFRX) United States $0.164B 0.00
Neon Therapeutics (NTGN) United States $0.161B 0.00
Molecular Templates (MTEM) United States $0.158B 0.00
Ardelyx (ARDX) United States $0.152B 0.00
ElectroCore (ECOR) United States $0.151B 0.00
Redhill Biopharma (RDHL) Israel $0.148B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.134B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.133B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.131B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.130B 0.00
Jounce Therapeutics (JNCE) United States $0.127B 0.00
DURECT (DRRX) United States $0.125B 0.00
Cardiome Pharma (CORV) Canada $0.122B 0.00
Adherex Technologies (FENC) United States $0.122B 0.00
ProNAi Therapeutics (SRRA) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
Iterum Therapeutics (ITRM) Ireland $0.108B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
Immune Design (IMDZ) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.088B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.087B 0.00
Melinta Therapeutics (MLNT) United States $0.087B 0.00
CTI BioPharma (CTIC) United States $0.086B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.078B 7.70
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
Achaogen (AKAO) United States $0.077B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
KemPharm (KMPH) United States $0.071B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 38.00
Ampio Pharmaceuticals (AMPE) United States $0.057B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.050B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Mannatechorporated (MTEX) United States $0.048B 0.00
Capnia (SLNO) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.03
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
Lipocine (LPCN) United States $0.031B 0.00
Trillium Therapeutics (TRIL) Canada $0.030B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Biomerica (BMRA) United States $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Aviragen Therapeutics (VXRT) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 6.95
Pain Therapeutics (PTIE) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Shineco (TYHT) China $0.014B 1.58
Regulus Therapeutics (RGLS) United States $0.013B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Aradigm (ARDM) United States $0.009B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00